Clinical Trial

Molecular Signatures of Cutaneous Dupilumab Response

Name: Molecular Signatures of Cutaneous Dupilumab Response — clinical trial record (NCT05858619)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This study examines the effect of IL4RA blockade with dupilumab on the immune cells of atopic dermatitis skin lesions.

Trial Details

NCT Number	NCT05858619
Lead Sponsor	University of California, San Francisco
Conditions	Atopic Dermatitis
Enrollment	15 participants
Start Date	2023-02-01
Primary Completion	2028-02-01 (estimated)
Study Completion	2028-02-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-04